TR201720515A2 - Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu - Google Patents

Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu Download PDF

Info

Publication number
TR201720515A2
TR201720515A2 TR2017/20515A TR201720515A TR201720515A2 TR 201720515 A2 TR201720515 A2 TR 201720515A2 TR 2017/20515 A TR2017/20515 A TR 2017/20515A TR 201720515 A TR201720515 A TR 201720515A TR 201720515 A2 TR201720515 A2 TR 201720515A2
Authority
TR
Turkey
Prior art keywords
dosage form
oral dosage
solid oral
form containing
containing linagliptin
Prior art date
Application number
TR2017/20515A
Other languages
English (en)
Inventor
Türkyilmaz Ali̇
Pehli̇van Akalin Nur
Ergun Donmez Merve
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/20515A priority Critical patent/TR201720515A2/tr
Priority to PCT/TR2018/050812 priority patent/WO2019203755A2/en
Priority to EP18914956.0A priority patent/EP3723761A4/en
Priority to CA3085455A priority patent/CA3085455C/en
Publication of TR201720515A2 publication Critical patent/TR201720515A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş, linagliptin ve en az bir bağlayıcı içeren katı oral dozaj formu ile ilgilidir.
TR2017/20515A 2017-12-15 2017-12-15 Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu TR201720515A2 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2017/20515A TR201720515A2 (tr) 2017-12-15 2017-12-15 Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu
PCT/TR2018/050812 WO2019203755A2 (en) 2017-12-15 2018-12-14 A solid oral dosage form comprising linagliptin
EP18914956.0A EP3723761A4 (en) 2017-12-15 2018-12-14 SOLID ORAL DOSAGE FORM WITH LINAGLIPTIN
CA3085455A CA3085455C (en) 2017-12-15 2018-12-14 A solid oral dosage form comprising linagliptin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/20515A TR201720515A2 (tr) 2017-12-15 2017-12-15 Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu

Publications (1)

Publication Number Publication Date
TR201720515A2 true TR201720515A2 (tr) 2019-07-22

Family

ID=67900883

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/20515A TR201720515A2 (tr) 2017-12-15 2017-12-15 Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu

Country Status (4)

Country Link
EP (1) EP3723761A4 (tr)
CA (1) CA3085455C (tr)
TR (1) TR201720515A2 (tr)
WO (1) WO2019203755A2 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022173406A1 (en) * 2021-02-15 2022-08-18 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A process for formulations of linagliptin or a pharmaceutically acceptable salt thereof
WO2024136773A1 (en) * 2022-12-21 2024-06-27 Santa Farma Ilac Sanayii A.S. Stable pharmaceutical composition comprising linagliptin
WO2025144125A1 (en) * 2023-12-27 2025-07-03 Santa Farma Ilac Sanayii A.S. Stable pharmaceutical composition with improved genotoxic impurity profile

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY32427A (es) * 2009-02-13 2010-09-30 Boheringer Ingelheim Internat Gmbh Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
WO2013128379A2 (en) 2012-02-27 2013-09-06 Dr. Reddy's Laboratories Limited Crystalline polymorphic forms of linagliptin
JP2015533134A (ja) * 2012-10-09 2015-11-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 錠剤の機械的安定性に適切な少なくとも１種の水和物形成活性物質及び／又はアジュバントを含有する機械的に安定な錠剤、特にアルギニン含有錠剤の製造における選択的に水分調整された打錠材料の使用
WO2014080383A1 (en) * 2012-11-26 2014-05-30 Ranbaxy Laboratories Limited Pharmaceutical composition of dipeptidyl peptidase-iv (dpp-iv) inhibitors in combination with other antidiabetics
WO2014080384A1 (en) 2012-11-26 2014-05-30 Ranbaxy Laboratories Limited Pharmaceutical composition of linagliptin
CN106138059A (zh) * 2015-03-27 2016-11-23 天津汉瑞药业有限公司 一种稳定的利格列汀药物组合物
EP3156048A1 (en) * 2015-10-13 2017-04-19 Galenicum Health S.L. Stable pharmaceutical composition of linagliptin in the form of immediate release tablets

Also Published As

Publication number Publication date
WO2019203755A2 (en) 2019-10-24
WO2019203755A3 (en) 2020-01-16
CA3085455A1 (en) 2019-10-24
EP3723761A2 (en) 2020-10-21
CA3085455C (en) 2022-08-16
EP3723761A4 (en) 2021-06-30

Similar Documents

Publication Publication Date Title
CY1123920T1 (el) Αντιγριπικο πολυκυκλικο παραγωγο πυριδονης και προφαρμακο αυτου
CY1121390T1 (el) Πυρρολοβενζοδιαζεπινες και συζευγματα αυτων
TR201900331T4 (tr) Bir aerosol - üretici sistem için kartuş.
MA43187A (fr) Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
MA45809A (fr) Promédicaments de pth
EP3463277A4 (en) FORMULATIONS FOR SUBSTITUTED 3-PYRROLIDINES, COMPOSITIONS THEREFOR AND USES THEREOF
CY1123465T1 (el) Αντιβακτηριακες ενωσεις ευρεως φασματος
HUE058662T2 (hu) Ciklikus dinukleotidok mint rákellenes szerek
IL286651A (en) Anti-viral and anti-tumoral compounds
TR201904120T4 (tr) Konnektör parçası.
TR201720515A2 (tr) Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu
TR201721824A2 (tr) Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon
BR112017024126A2 (pt) composições farmacêuticas e uso das mesmas
TR201914406A2 (tr) Sapropteri̇n di̇hi̇droklorür ve en az bi̇r farmasöti̇k eksi̇pi̇yan i̇çeren kati oral farmasöti̇k formülasyonlar
TR201910339T4 (tr) Mala.
TR201914420A2 (tr) Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar
EP4095218C0 (en) ALTERNATIVE POWDER FUEL
EP3313392A4 (en) Platinum compounds, compositions and uses thereof
MA56506A (fr) Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées
TR201819130T4 (tr) Sulu Formülasyonlar, Bunların Üretimi Ve Kullanımı
TR201818986A2 (tr) İvabradi̇n ve metoprolol i̇çeren kati oral farmasöti̇k kompozi̇syonlar
EP3880190A4 (en) ANTI-CANCER COMPOSITION
TR201818864A2 (tr) Di̇meti̇l fumarat ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon
TR201818859A2 (tr) Di̇meti̇l fumarat ve en az bi̇r kas gevşeti̇ci̇ ajan i̇çeren bi̇r kombi̇nasyon
TR201722970A2 (tr) Flurbi̇profen-li̇dokai̇n ve seti̇lpi̇ri̇di̇nyum i̇çeren farmasöti̇k bi̇leşi̇mler